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Research, Semmelweis University, Budapest, Hungary.A phosphate-linked antiporter activity of the glucose-6-phosphate transporter (G6PT) has been
recently described in liposomes including the reconstituded transporter protein. We directly inves-
tigated the mechanism of glucose-6-phosphate (G6P) transport in rat liver microsomal vesicles. Pre-
loading with inorganic phosphate (Pi) did not stimulate G6P or Pi microsomal inward transport. Pi
efﬂux from pre-loaded microsomes could not be enhanced by G6P or Pi addition. Rapid G6P or Pi
inﬂux was registered by light-scattering in microsomes not containing G6P or Pi. The G6PT inhibitor,
S3483, blocked G6P transport irrespectively of experimental conditions. We conclude that hepatic
G6PT functions as an uniporter.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction Original evidence in liver ER-derived vesicles, i.e. microsomes,The glucose-6-phosphate transporter (G6PT, also known as
SLC37A4) is an integral endoplasmic reticulum (ER) protein, which
mediates the entry of the cytosolicmetabolite glucose-6-phosphate
(G6P) into the ER lumen [1,2]. In the ER lumen, G6P is the substrate
of at least two enzymes: the glucose-6-phosphatase (EC 3.1.3.9.,
G6Pase), and the hexose-6-phosphate dehydrogenase (EC
1.1.1.47., H6PD) [1,2]. The G6PC isoform of the former enzyme is
highly expressed in the glucogenic organs liver and kidney and reg-
ulates blood glucose homeostasis; other isoforms, namely G6PC2
and G6PC3, are expressed in various non glucogenic tissues [3 for
a review]. The inherited deﬁciency of G6PC and G6PT causes glyco-
gen storage disease type 1 a and type 1 non-a, respectively, since
G6P hydrolysis is prevented, particularly in glucogenic tissues [1].chemical Societies. Published by E
er;G6P,glucose-6-phosphate;
Pase, glucose-6-phosphatase;
0-diisothiocyanostilbene-2,20-
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y and Clinical Experimentalsuggested that G6PT works as a facilitative bi-directional trans-
porter [4–8]. More recently, it has been shown that G6PT, once
overexpressed in COS-1 cells and subsequently reconstituted in
liposomes, behaves as a phosphate-linked antiporter [9,10]. In
view of this discrepancy, in the present paper we have directly
investigated this point. In particular, we aimed at evidence the pos-
sible G6P-phosphate antiport activity of G6PT in native rat liver
microsomes. We assumed this model to reﬂect the physiological
conditions of the liver ER. Indeed, microsomal vesicles from the li-
ver have been considered for a long time an equivalent of ER
in vitro [e.g. see 11] and have been used in a large number of stud-
ies related to ER transport (see 2 for a review). The present results
compellingly indicate that in liver microsomes G6PT does not
operate as an antiporter. We conclude that liver G6PT works as a
facilitative bidirectional G6P uniporter.
2. Materials and methods
2.1. Materials
G6P (dipotassium salt), mannose-6-phosphate (disodium salt),
alamethicin, NADPH, and 4,40-diisothiocyanostilbene-2,20-disul-
fonic acid (DIDS) were from Sigma. Na3VO4 was from Fisher Sci-
ence Co. S3483 was a gift of Aventis Pharma, Frankfurt, Germany.lsevier B.V. All rights reserved.
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ican Radiolabeled Chemicals Inc. 32Pi disodium phosphate
1000 mCi/mmol was from Perkin Elmer. [3H]H2O (1 mCi/g) and
[14C(C)]inulin (500 mCi/g) were from DuPont NEN. Cellulose ace-
tate/nitrate ﬁlter membranes (pore size 0.22 lm) were from Milli-
pore. All other chemicals were of analytical grade.
2.2. Preparation of liver microsomes
Each microsomal preparation was from three pooled livers of
24 h-fasted male Sprague–Dawley rats (180–230 g), and micro-
somes were prepared as reported [7]. Microsomal fractions were
resuspended in a buffer containing (mM): KCl, 100; NaCl, 20;
MgCl2, 1; 3-(N-morpholino)propanesulfonic acid (Mops), 20, pH
7.2. The suspensions were rapidly frozen and maintained under li-
quid N2 until used. Microsomal water space was measured with
[3H]H2O and [3H(C)]-Inulin as non-permanent compound [7].
2.3. Loading of microsomes with inorganic phosphate anions
In some experiments, microsomes (20 mg protein/ml) were
incubated in the KCl/Mops buffer pH 7.2 in the presence of 5 mM
K-phosphate buffer (pH 7.2) for 1 h at 22 C. In other experiments,
to increase the intravesicular phosphate concentration, micro-
somal vesicles (20 mg protein/ml) in the KCl/Mops buffer pH 7.2
were opened/resealed by freezing/thawing three times in the pres-
ence of 5 mM K-phosphate buffer (pH 7.2), essentially as reported
[8], except that suspensions were frozen in liquid nitrogen for
5 min and subsequently thawed 5 min at 37 C, for each cycle,
and no detergent was used.
The amount of intravesicular inorganic phosphate (Pi) was eval-
uated by adding trace amounts of 32Pi to the microsomal suspen-
sions before incubating or the freezing/thawing procedure;
aliquots (20 ll) were used for rapid ﬁltration measurements as de-
tailed below.
2.4. Uptake of G6P
After Pi pre-loading, microsomal suspensions were immediately
20-fold diluted in the KCl/Mops buffer pH 7.2 containing the de-
sired amounts of G6P plus [14C(U)]G6P (24 lCi/ml). At the indi-
cated time intervals, aliquots (0.1 ml) were rapidly withdrawn
and ﬁltered through cellulose acetate/nitrate ﬁlters (pore size
0.22 lm) and washed with 4 ml of Hepes (20 mM) buffer pH 7.2
containing 250 mM sucrose and 1 mM DIDS. The radioactivity
associated with microsomes retained by ﬁlters was measured by li-
quid scintillation counting [7]. To distinguish the intravesicular
and the bound radioactivity, alamethicin (0.1 mg/ml) was added
to parallel incubates and the alamethicin-releasable portion of
radioactivity was regarded as intravesicular [7]. The alamethicin-
treated microsomes retained amounts of radioactivity615% of that
associated to untreated microsomes.
2.5. Release/uptake of inorganic phosphate
For evaluating the microsomal release of Pi, microsomes were
treated by freezing/thawing in the presence of 5 mM K-phosphate
buffer pH 7.2 plus 32P (75 lCi/ml) and then 20-fold diluted in the
KCl/Mops (i) with or without 1 mM G6P, and (ii) with or without
5 mM Pi. For evaluating the uptake of Pi, microsomes were treated
by freezing/thawing in the presence (or in the absence, control) of
5 mM K-phosphate buffer pH 7.2 and then 20-fold diluted in the
KCl/Mops buffer pH 7.2 containing 5 mM K-phosphate plus 32Pi
(75 lCi/ml). At the indicated time intervals, aliquots (0.1 ml) were
rapidly withdrawn and Pi vesicular content was measured as de-
scribed above.2.6. Light-scattering measurement of the microsomal permeability to
G6P and Pi
The permeability of the microsomal membranes towards G6P
and Pi wasmeasured by the continuous detection of the osmotically
induced changes in size and shape of microsomal vesicles by light-
scattering [6 andRefs. therein].Microsomal vesicles (20 mgprotein/
ml) were frozen and thawed in a hypotonicmedium (5 mM1,4-pip-
erazinediethanesulfonic acid potassium salt, pH 7.0) to release
intravesicular components, recovered by rapid centrifugation [8],
resuspended in the hypotonic medium to have 100 lg protein per
ml, and equilibrated for 3 h at 22 C. Light-scattering of microsomal
suspensions was monitored at 400 nm at right angles to the incom-
ing light beam using a Cary Eclipse ﬂuorescence spectrophotometer
(Varian), equipped with a temperature-controlled cuvette holder
(22 C) andmagnetic stirrer. Vesicle shrinking (increased light-scat-
tering) and swelling (decreased light-scattering) were detected
after the addition of a small volume (<5% of the total incubation vol-
ume) of concentrated and neutralised solutions of the compounds
to be tested. Light-scattering intensity was acquired each 0.2 s.
The freezing/thawing procedure did not modify the pattern in light
scattering signal as veriﬁed in preliminary experiments.
2.7. Other assays
Intactness of microsomal vesicles checked by measuring the la-
tency of mannose-6-phosphatase activity [7] was greater than 90%
independently of any treatment employed. Glucose-6-phosphatase
activity was measured as reported [7]. Pi content of microsomal
vesicles was measured according to [12].
2.8. Statistical analysis
Results are expressed as means ± S.D. Results were compared
using the Student’s two-tailed t-test: P < 0.05 was considered sta-
tistically signiﬁcant.
3. Results
3.1. Uptake of radiolabeled G6P by microsomes pre-loaded with Pi
To evidence a putative G6P–Pi antiport activity, a concentrated
suspension of liver microsomes (20 mg of protein per ml) was pre-
loaded with Pi by incubation in the presence of 5 mM K-phosphate
buffer pH 7.2, for 1 h. The incubation resulted in the loading of
microsomal vesicles of 7.1 nmol Pi per mg of protein. Assuming a
vesicular water space of 3.1 ll/mg protein, and an evenly distribu-
tion of the anion in microsomal vesicles, an intravesicular Pi con-
centration of 2.3 mM could be calculated. The uptake of G6P was
started by a 20-fold-dilution of the microsomal suspension in the
Pi-free buffer containing 1 mM G6P (and the [14C(U)] G6P tracer).
The dilution creates a gradient between intra- and extra-vesicular
Pi concentration (2.3 mM versus 0.25 mM), which is expected to
favour G6P uptake in the case that a G6P–Pi antiport is operative.
By contrast, the G6P uptake was not increased in Pi loaded as com-
pared to control (not loaded with Pi) microsomes (Fig. 1 A).
Similar experiments were run in microsomes pre-loaded using
a freezing/thawing protocol. To this end, microsomal vesicles were
opened/resealed in the presence or in the absence of 5 mM Pi. This
manoeuvre increased the microsomal Pi loading up to 12.7 nmol
per mg of protein, which should correspond to an intravesicular
Pi concentration of 4.1 mM. Despite the increased gradient be-
tween intravesicular Pi and extravesicular G6P concentrations,
the uptake of G6P was almost identical in Pi loaded and control
microsomes (Fig. 1 B). In the experiments of both Fig. 1A and B,
the prototypic G6PT inhibitor, S3483 [13], almost completely
inhibited the G6P uptake.
Fig. 1. Pi pre-loading of liver microsomal vesicles does not affect the uptake of 1 mM G6P. Microsomes were pre-loaded by incubation in the presence of 5 mM Pi (panel A) or
by a freezing/thawing procedure (panel B), as detailed in ‘‘Section 2’’). In panel C, microsomes pre-loaded with 5 mM Pi by the freezing/thawing procedure were pre-
incubated with 100 lM vanadate for 10 min at 22 C to inhibit G6Pase activity. G6P uptake was started upon dilution in a Pi-free medium containing 1 mM G6P plus trace
amounts of [14C(U)]G6P. Where indicated in ﬁgure, 30 lM S3483 was added to the media for the Pi loading procedures, as well as in the dilution medium. G6P uptake was
measured by a rapid ﬁltration assay as detailed in ‘‘Section 2’’. Data are means S.D. of three independent experiments.
Fig. 2. Pi pre-loading of liver microsomal vesicles does not affect the uptake of 50 lMG6P. Microsomes were pre-loaded by incubation in the presence of 5 mM Pi (panel A) or
by a freezing/thawing procedure (panel B), as detailed in ‘‘Section 2’’. G6P uptake was started upon dilution in a Pi-free medium containing 50 lM G6P plus trace amounts of
[14C(U)]G6P. Other experimental conditions are as reported in the legend to Fig. 1. Data are means S.D. of three independent experiments.
3356 P. Marcolongo et al. / FEBS Letters 586 (2012) 3354–3359Once in the (liver) ER/microsomal lumen, G6P is the substrate of
at least two enzymes: G6Pase, and H6PD [1–2,4]. In case of G6Pase,
the exit rate from microsomal vesicles of the reaction product glu-
cose is lower than the G6Pase-mediated hydrolysis rate [1,2,7]. The
product of H6PD, 6-phosphogluconate also accumulates within the
microsomes [4]. Thus, upon the addition of [14C(U)]G6P, the lumi-
nal presence of radiolabelled G6P, glucose and 6-phosphogluco-
nate should be considered. To evaluate the net [14C(U)]G6P
uptake, the contribution of the intravesicular [14C]glucose pro-
duced by G6Pase activity to the total intravesicular [14C] radioac-
tivity was abolished by inhibiting the enzyme with 100 lM
vanadate [6–8]. Moreover, freezing/thawing of microsomes abol-
ished H6PD activity in the microsomal lumen (see below).
100 lM vanadate resulted in the maximal inhibition of G6Pase
activity (94.3%, measured in ancillary experiments). As demon-
strated in Fig. 1 C, the apparent uptake of labelled G6P was approx-
imately ﬁvefold lower as compared to microsomes without
vanadate treatment (compare to Fig. 1 A and B), which is essen-
tially in agreement with the direct measurement of intravesicular
[14C(U)]G6P and [14C(U)]glucose content [7]. Under these experi-mental conditions too, there was no stimulatory effect by micro-
somal Pi pre-loading on G6P uptake (Fig. 1C). Both in Pi pre-
loaded and control microsomes, the G6PT inhibitor S3483 largely
blocked G6P uptake (Fig. 1C).
The uptake of a lower concentration of G6P (i.e. 50 lM) was also
evaluated (Fig 2). Under these conditions, the ratio between the
intravesicular concentration of Pi (in the millimolar range) and
the extravesicular concentration of G6P (50 lM) should even more
favour a putative exchange between the two anions. However,
either in the case of microsomal Pi loading by pre-incubation with
Pi (Fig. 2A) or by the freezing/thawing procedure (Fig. 2B) the up-
take of radioactivity was almost identical in Pi pre-loaded and in
control microsomes. Again, the uptake was blocked by the G6PT
inhibitor S3483 (Fig. 2A). When microsomal vesicles have not been
opened/resealed (Fig. 2A) the apparent uptake of [14C(U)]G6P was
much over the passive equilibrium of G6P (approximately 4.5-
folds). This can be explained by the intraluminal storage of
[14C]6-phosphogluconic acid due to the H6PD activity [8,14]. In
fact, opening/resealing of the microsomal vesicles resulted in a
much lower [14C(U)]G6P uptake (Fig. 2B). In this latter case, the
Fig. 3. G6P inﬂux into liver microsomal vesicles evaluated by light-scattering. Liver microsomes were treated by freezing/thawing, recovered by rapid centrifugation,
resuspended in an hypotonic medium and equilibrated at 22 C for 3 h. Light-scattering of microsomal suspensions was monitored at 400 nm at right angles to the incoming
light beam using a ﬂuorescence spectrophotometer. Where indicated by arrows, a small volume of 0.25 M G6P was added to incubates to have a ﬁnal concentration of 10
(panel A) or 5 (panel B) mM of the hexose phosphate. Where indicated, 100 lM vanadate or 30 lM S3483 was added to the suspension 10 min before starting the assay. The
light-scattering signal was acquired each 0.2 s in individual traces obtained in three (panel A) or four (panel B) separate experiments, and the traces shown are the mean of
the individual traces. The G6P inﬂux phase was assumed to be from the maximal intensity in light-scattering till the steady state of the lowest intensity in light-scattering was
reached. At 10 mM G6P (panel A), the mean ± S.D. values of t½ of inﬂux rate - calculated from the individual traces – were 4.59 ± 0.50 s and 6.56 ± 0.39 s for control and
vanadate-treated microsomes, respectively; this difference was statistically signiﬁcant: P < 0.05. At 5 mM G6P (panel B), the mean ± S.D. values of t½ of inﬂux rate were
2.43 ± 0.54 s and 3.37 ± 0.68 s for control and vanadate-treated microsomes, respectively; this difference was not statistically signiﬁcant. Both with 10 (panel A) and 5 (panel
B) G6P, S3483 treatment almost completely blocked microsomal G6P inﬂux.
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large dilution in the extravesicular medium, virtually abolished
H6PD activity [14], thus reducing the apparent uptake of
[14C(U)]G6P.
3.2. Microsomal G6P permeability evaluated by a light-scattering
technique
As previously reported [6 and Refs. therein, 7], the permeability
of microsomal vesicles towards different solutes can be estimated
by a light-scattering technique. The assay was run after opening/
resealing of the microsomal vesicles in order to release eventual
intraluminal Pi and to avoid possible anion exchange. No detect-
able Pi anions were measured in the acid extract of these
microsomes.
The addition of either 10 mM (Fig. 3 A) or 5 mM G6P (Fig. 3 B)
caused a rapid shrinkage of microsomes (increase in light-scatter-
ing) followed by a swelling phase (decrease in light-scattering),
which reﬂects G6P inﬂux rate. Noticeably, the swelling phase
was almost completely abolished by the G6PT inhibitor S3483, at
both the G6P concentrations (Fig. 3 A and B). The treatment of
microsomes with 100 lM vanadate somewhat reduced the micro-
somal permeability to G6P: at 5 mMG6P the effect of vanadate was
somehow evident but not statistically signiﬁcant (Fig. 3 B), at
10 mM G6P this effect was more evident and statistically signiﬁ-
cant (Fig. 3 A).
3.3. Release and uptake of 32Pi in microsomes pre-loaded with Pi
Previous data in proteoliposomes containing the reconstituted
G6PT protein indicate that the transporter can also act as a Pi–Pi
antiporter, and that the G6P–Pi and Pi–Pi antiporter activity canbe observed in both directions [9,10]. To ascertain these points in
the liver microsomal system, (i) microsomes were pre-loaded with
5 mM Pi, plus trace amounts of 32Pi and the Pi efﬂux was moni-
tored upon dilution with or without cold 1 mM G6P (Fig. 4 A) or
5 mM Pi (Fig. 4 B), and (ii) the inﬂux of Pi (5 mM, plus 32Pi) was
evaluated in microsomes preloaded with 5 mM cold Pi (Fig. 4 C).
As shown in Fig. 4 A, no increase in the rate of spontaneous Pi
release was induced by G6P. Pi release and uptake rate were not af-
fected by the presence of an almost equal concentration of the an-
ion either at the inner or at outer side of the microsomal
membrane (Fig. 4 B and 4 C).
3.4. Microsomal Pi permeability evaluated by a light-scattering
technique
The microsomal permeability to Pi (5 mM) was also investi-
gated by light-scattering. As shown in Fig. 4D, the microsomal ves-
icles appeared to be fairly permeable to Pi, but with lower rate of
entry (t½ = 24.43 s) as compared to that observed with same con-
centration of G6P (i.e. 2.43 s, Fig 4 B). Vanadate (100 lM) did not
affect the microsomal Pi permeability (not shown).
4. Discussion
The present results strongly suggest that, in native liver micro-
somal vesicles, G6PT operates as a facilitative uniporter. Impor-
tantly, the present results militate against the possibility that
G6PT operates as either a G6P–Pi or a Pi–Pi antiport. Actually,
pre-loading microsomal vesicles with Pi did not increase the up-
take of both G6P and Pi as evaluated radioisotopically. Also, Pi re-
lease from Pi pre-loaded microsomal vesicles was not enhanced in
media containing G6P or Pi.
Fig. 4. Release and uptake of 32Pi in microsomes pre-loaded with Pi, and Pi inﬂux into liver microsomal vesicles evaluated by light-scattering. Microsomes were pre-loaded
with 5 mM Pi plus trace amounts of 32Pi by a freezing/thawing procedure, and 32Pi release was started upon dilution in a Pi-free medium containing 1 mM G6P (panel A) or
5 mM Pi (panel B). In panel C, microsomes were pre-loaded with 5 mM cold Pi by a freezing/thawing procedure and Pi uptake was started upon dilution in a medium
containing 5 mM Pi plus trace amounts of 32Pi. Microsomal Pi content was measured by a rapid ﬁltration assay as detailed in ‘‘Section 2’’. Data are means (S.D. of three
independent experiments. Panel D: the experimental conditions for the light-scattering measurements and the calculation of t½ inﬂux rate are those reported in the legend to
Fig. 3. Where indicated by the arrow, a small volume of 0.25 M Pi (as K-Pi buffer, pH 7) was added to incubates to have a ﬁnal concentration of 5 mM Pi. The light-scattering
signal was acquired each 0.2 s in individual traces of four separate experiments, and the trace shown is the mean of the individual traces. The mean ± SD values of t½ of inﬂux
rate – calculated from the individual traces – was 24.43 ± 5.0 s.
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reﬂects the net G6P uptake – up to the equilibrium between the in-
tra and extra vesicular ﬂuids – but also the intravesicular entrap-
ping of G6P-derived 14C-labelled metabolites, e.g. glucose and
phosphogluconic acid (1–3, 4, 7). The net uptake of G6P was mea-
sured upon the almost complete inhibition of the G6Pase activity
with vanadate and the elimination of H6PD activity by freezing
and thawing. Even under these conditions, G6P uptake was not
enhanced at all by microsomal Pi pre-loading. Consistently, light-
scattering measurements revealed a high permeability of micro-
somal vesicles for G6P, which do not contain any Pi inside, even
when the G6Pase-mediated intraluminal Pi generation was sup-
pressed by vanadate. These observations also indicate that the pos-
sibility for an exchange between Pi generated by the G6Pase
activity within the vesicle lumen and the extra vesicular G6P is
unlikely.
A high permeability of liver microsomes for G6P has been pre-
viously described in light-scattering assays and assumed to reﬂect
G6PT activity because of its high speciﬁcity [e.g., 6]. Here we add
an important piece of evidence to this interpretation since the
G6PT inhibitor S3483 blocked the G6P inﬂux into microsomal ves-
icles. Light-scattering measurements also conﬁrmed that Pi could
enter microsomal vesicles independently of intraluminal Pi
content.Previous experimental data are consistent with the present
ones. It was shown that intravesicular G6P formed by phospho-
transferase activity of G6Pase [15], leaves microsomal lumen
through an S3483-inhibitable transporter, allegedly G6PT [4]; in
this case, both G6P and Pi exit from the vesicles in the same direc-
tion. Moreover, treating liver microsomes with PbCl2 resulted in
the intravesicular entrapping of Pi derived by G6P hydrolysis as
Pb–Pi complexes, which markedly reduced Pi efﬂux [8]; nonethe-
less, the rate of G6P hydrolysis – reﬂecting the rate of G6P inﬂux
– was not modiﬁed [4].
At variance with the present results, G6P–Pi and Pi–Pi antiport
activities have been observed in proteoliposomes including the
reconstituted G6PT protein [9,10]. An additional discrepancy be-
tween those and the present study are that vanadate was not
inhibitory on the transport in our experiments. Because of the re-
sults shown in Figs. 1 and 3 we can conclude that vanadate – at
least at 100 lM concentration, sufﬁcient to inhibit G6Pase activity
– does not block G6P transport. Instead, vanadate by inhibiting
microsomal G6Pase activity does not allow the intravesicular accu-
mulation of radiolabeled glucose derived from radiolabeled G6P,
which results in a virtual lower uptake. The fact that an apparent
(and any way minor) vanadate inhibition of microsomal G6P per-
meability was observed in light-scattering measurements (Fig. 3)
can be logically explained by the lack of intra vesicular formation
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acceleration of the swelling phase in control microsomes.
The fact that G6PT operates as a G6P–Pi antiport once reconsti-
tuted in proteoliposomes can be theoretically explained in several
ways. The transporter protein might be folded and oriented, either
in the host cell ER membrane (COS-1 cells) or (and) in the reconsti-
tuted proteoliposomal membrane, differently from the native envi-
ronment, i.e. the liver ER membrane. Also, the high content in the
overexpressed reconstituted G6PT versus the content of other
transporters (e.g. that for Pi, K+, Na+) of the microsomes used for
the proteoliposomal assembly can some how favour exchange
reactions. It should be noted that for the G6P–Pi exchange the stoi-
chiometry was far from the equilibrium: 0.2 mM for the former
versus 50 mM for the latter [9,10]. Moreover, the high concentra-
tions of external Pi/G6P applied – as competitive inhibitors – might
also osmotically inﬂuence the internal volume of the proteolipo-
somes, modifying the rate of the uptake.
In any event, our ﬁndings show that the G6PT works as a G6P
uniporter under circumstances resembling the (liver) physiological
conditions. In this respect, we should consider that cytosolic inor-
ganic Pi does not exceed a 5 mM concentration [16]. It can be ar-
gued that higher Pi concentrations are present in the ER lumen,
particularly at sites neighbouring the G6Pase enzyme. This argu-
mentation is, however, untenable since G6Pase activity does not
appear to be required for G6PT-mediated transport of G6P. Consis-
tently with this conclusion, no close vicinity between G6PT and
G6Pase proteins has been demonstrated, as a lack of FRET was ob-
served between the two ﬂuorescent proteins [17]. Under physio-
logical conditions another point deserves attention: G6Pase
activity is not the only source of intrareticular Pi, since ER Pi con-
tent can vary depending on ER Ca2+ storage [18 and Refs. therein],
glucuronidation [2], ATP hydrolysis [2] and, possibly, other
dephosphorylation reactions. This would imply, according to the
G6P–Pi exchange hypothesis, undesired interference with the rate
of G6P hydrolysis. Moreover, assuming that the exchange reaction
is the sole pathway for Pi efﬂux from ER to cytosol, additional se-
vere defects should be present in patients affected by the inherited
deﬁciency of G6PT, i.e. in glycogen storage disease type 1 non-a.
The observation that all the patients affected by glycogen storage
disease type 1 non-a – including those previously assumed to bear
a defect of an unknown gene encoding a putative ER Pi transporter
– present with mutations in G6PT/SLC37A4 [19], is obviously not
explained by either the exchanger hypothesis or by the fact that
G6PT works as a facilitative uniporter. Other explanations should
be forwarded.
Collectively, the present results compellingly indicate that, at
least in the major gluocogenic tissue, the liver, G6PT acts as a facil-
itative uniporter. This conclusion appears consistent with several
physiological considerations, but does not exclude that other gene
products related to G6PT – i.e. the SLC37A1 and SLC37A2 products,
poorly expressed in the liver [9] – may operate as G6P–Pi exchang-
ers, particularly in non glucogenic tissues/cells. This latter point
would deserve further investigation.Acknowledgements
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